Nalpropion Pharmaceuticals Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Nalpropion Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company. The company focuses on the treatment of weight loss with the use of a medication called Contrave.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 9171 Towne Centre Drive
  • Suite 270
  • San Diego, CA 92122
  • United States
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • 9171 Towne Centre Drive
  • Suite 270
  • San Diego, CA 92122
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nalpropion Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nalpropion Pharmaceuticals‘s full profile, request access.

Request a free trial

Nalpropion Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nalpropion Pharmaceuticals‘s full profile, request access.

Request a free trial

Nalpropion Pharmaceuticals Acquisitions (1)

Nalpropion Pharmaceuticals’s most recent deal was a Merger/Acquisition with Orexigen Therapeutics for . The deal was made on 13-Aug-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Orexigen Therapeutics 13-Aug-2018 Merger/Acquisition Pharmaceuticals
To view Nalpropion Pharmaceuticals’s complete acquisitions history, request access »

Nalpropion Pharmaceuticals FAQs

  • Where is Nalpropion Pharmaceuticals headquartered?

    Nalpropion Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Nalpropion Pharmaceuticals in?

    Nalpropion Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Nalpropion Pharmaceuticals a private or public company?

    Nalpropion Pharmaceuticals is a Private company.

  • What is Nalpropion Pharmaceuticals’s current revenue?

    The current revenue for Nalpropion Pharmaceuticals is .

  • How much funding has Nalpropion Pharmaceuticals raised over time?

    Nalpropion Pharmaceuticals has raised $9.1M.

  • Who are Nalpropion Pharmaceuticals’s investors?

    Pernix Ireland Pain Designated Activity Company has invested in Nalpropion Pharmaceuticals.

  • When was Nalpropion Pharmaceuticals acquired?

    Nalpropion Pharmaceuticals was acquired on 27-Sep-2019.

  • Who acquired Nalpropion Pharmaceuticals?

    Nalpropion Pharmaceuticals was acquired by Pernix Therapeutical Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process